Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Family Navigation to Improve ADHD Treatment Adherence for Minority Children

A legfontosabb adatok

Ki végzi
Children's Hospital Medical Center, Cincinnati
Hol
Cincinnati (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
108 fő vett részt
Kezdés
2021. máj. 14.
Befejezés
2026. júl. 30.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • I2-ART
  • Usual care
A regiszteradat frissítve
2026. augusztus 14.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 16 feltétel megnézéseKevesebb

Ki vehet részt

  • Currently providing care for children with ADHD as psychologists, general pediatricians, or developmental pediatricians
  • > 18 years old
  • Any race/ethnicity
  • Having experience working as family navigator and/or community health worker
  • Latinx (Lx) or African American (AA)
  • > 18 years old
  • Phase 1a: current or former caregiver of a child with ADHD, with and without experience with ADHD treatment
  • Phases 1b and 2: current caregiver of a child (aged 7-11 years) with ADHD who is ADHD treatment-naïve at study enrollment
  • Lx or AA
  • > 18 years old

Ki nem vehet részt

  • Unable to read/speak either English or Spanish
  • Family navigators
  • Unable to read/speak either English or Spanish
  • Caregivers
  • Unable to read/speak either English or Spanish

Egyéb feltételek

  • Clinicians

Helyszínek itt: Egyesült Államok

  • Cincinnati Children's Hospital Medical CenterCincinnati, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

ADHD is the most common pediatric neurodevelopmental disorder and is associated with significant long-term impairments. Current guidelines recommend stimulant medication and/or behavioral therapy as first-line treatments for ADHD. Despite evidence that consistent treatment is important for effectively managing ADHD symptoms, treatment adherence remains suboptimal and is especially problematic among minority children. Hypothesized reasons for racial/ethnic disparities in ADHD treatment include uncertainties about medication efficacy and side effects, distrust of the health care system, and decreased access to mental health services. This study aims to develop and test the I2-ART intervention to improve treatment adherence in minority (Latinx and African American) children with ADHD. The proposed study involves three ORBIT phases: During phase 1a, the investigators will conduct focus groups with key stakeholders (i.e., caregivers, clinicians, and family navigators, n=24) to identify and develop I2-ART's basic elements. Next, during phase 1b, the investigators will train four family navigators to implement I2-ART with caregivers of treatment-naïve children with ADHD (n=8-12) in order to determine feasibility and acceptability. In phase 2, the investigators will use phase 1b findings to modify I2-ART as needed, and then will evaluate the preliminary efficacy of the revised I2-ART (n=40), compared to the "usual care" control condition (n=20), on ADHD treatment adherence. The preliminary data collected during the proposed study will inform a subsequent R01 randomized controlled trial to examine I2-ART efficacy.

A vizsgálat 2 csoportja

  • I2-ART GroupMár használt kezelés, összehasonlításként

    I2-ART intervention will be modeled based on the Parent Empowerment Program model. It will use methods of adult learning, direct instruction to share knowledge or techniques for practice, group support, modeling, vicarious learning, and practice opportunities (i.e., role rehearsals). I2-ART training includes 40 hours of didactic and interactive sessions (10 sessions of 4 hours each) covering the following areas: 1) conceptual framework, 2) listening, engagement, and boundary-setting skills; 3) ADHD psychoeducation (e.g., diagnosis, treatment, shared decision-making tools), and 4) service options. The caregivers in the I2-ART group will receive the intervention for 3 months. The I2-ART will be implemented by the family navigators and will include a 2-hour face-to-face meeting, at least three monthly in-person meetings, and intermittent contact between in-person meetings by phone calls, texts or emails, as determined by the family navigator-caregiver dyad.

    Kezelés: I2-ART

  • Control GroupPlacebo, összehasonlításként

    The caregivers in the control group will receive "usual care."

    Kezelés: Usual care

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Family Navigator Intervention to Improve ADHD- Related Treatment Adherence (I2-ART) for Minority Children
A regiszteradat frissítve
2026. augusztus 14.